Activities of telithromycin, erythromycin, fluoroquinolones, and doxycycline against Campylobacter strains isolated from Finnish subjects

Daniela Schönberg-Norio; Marja-Liisa Hänninen; Marja-Leena Katila; Suvi-Sirkku Kaukoranta; Markku Koskela; Erkki Eerola; Jaakko Uksila; Sini Pajarre; Hilpi Rautelin

doi:10.1128/AAC.50.3.1086-1088.2006

Activities of telithromycin, erythromycin, fluoroquinolones, and doxycycline against Campylobacter strains isolated from Finnish subjects

Antimicrob Agents Chemother. 2006 Mar;50(3):1086-8. doi: 10.1128/AAC.50.3.1086-1088.2006.

Authors

Daniela Schönberg-Norio¹, Marja-Liisa Hänninen, Marja-Leena Katila, Suvi-Sirkku Kaukoranta, Markku Koskela, Erkki Eerola, Jaakko Uksila, Sini Pajarre, Hilpi Rautelin

Affiliation

¹ Department of Bacteriology and Immunology, Haartman Institute, P.O. Box 21, FIN-00014 University of Helsinki, Helsinki, Finland.

Abstract

The in vitro susceptibilities of 478 Campylobacter jejuni and Campylobacter coli strains isolated from Finnish subjects during 2002 to 2004 were determined. Susceptibility to erythromycin remained high, and telithromycin did not offer any advantage over erythromycin. Reduced susceptibilities to fluoroquinolones and doxycycline were detected almost exclusively among isolates of foreign origin.

Publication types

Comparative Study
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / pharmacology*
Campylobacter / drug effects*
Campylobacter / genetics
Campylobacter / isolation & purification
Doxycycline / pharmacology*
Erythromycin / pharmacology*
Finland / epidemiology
Fluoroquinolones / pharmacology*
Humans
Ketolides / pharmacology*
Microbial Sensitivity Tests

Substances

Anti-Bacterial Agents
Fluoroquinolones
Ketolides
Erythromycin
telithromycin
Doxycycline